Last updated on March 2019

A Multicenter, Fixed-Dose, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of AR19 (Amphetamine Sulfate) in Adult Subjects (Ages 18-55) with Attention Deficit Hyperactivity Disorder (ADHD) - Protocol AR19.004


Brief description of study

AR19 versus placebo in Adult ADHD.

 

Clinical Study Identifier: TX216180

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.